Longitudinal Changes in Structural Connectivity in Young People at High Genetic Risk for Bipolar Disorder.


Journal

The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 29 3 2022
medline: 4 5 2022
entrez: 28 3 2022
Statut: ppublish

Résumé

Recent studies of patients with bipolar disorder or at high genetic risk reveal structural dysconnections among key brain networks supporting cognitive and affective processes. Understanding the longitudinal trajectories of these networks across the peak age range of bipolar disorder onset could inform mechanisms of illness onset or resilience. Longitudinal diffusion-weighted MRI and phenotypic data were acquired at baseline and after 2 years in 183 individuals ages 12-30 years in two cohorts: 97 unaffected individuals with a first-degree relative with bipolar disorder (the high-risk group) and 86 individuals with no family history of mental illness (the control group). Whole-brain structural networks were derived using tractography, and longitudinal changes in these networks were studied using network-based statistics and mixed linear models. Both groups showed widespread longitudinal changes, comprising both increases and decreases in structural connectivity, consistent with a shared neurodevelopmental process. On top of these shared changes, high-risk participants showed weakening of connectivity in a network encompassing the left inferior and middle frontal areas, left striatal and thalamic structures, the left fusiform, and right parietal and occipital regions. Connections among these regions strengthened in the control group, whereas they weakened in the high-risk group, shifting toward a cohort with established bipolar disorder. There was marginal evidence for even greater network weakening in those who had their first manic or hypomanic episode before follow-up. Neurodevelopment from adolescence into early adulthood is associated with a substantial reorganization of structural brain networks. Differences in these maturational processes occur in a multisystem network in individuals at high genetic risk of bipolar disorder. This may represent a novel candidate to understand resilience and predict conversion to bipolar disorder.

Identifiants

pubmed: 35343756
doi: 10.1176/appi.ajp.21010047
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-361

Auteurs

Gloria Roberts (G)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Alistair Perry (A)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Kate Ridgway (K)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Vivian Leung (V)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Megan Campbell (M)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Rhoshel Lenroot (R)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Philip B Mitchell (PB)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Michael Breakspear (M)

School of Psychiatry, University of New South Wales, Randwick, Australia (Roberts, Ridgway, Leung, Mitchell); Department of Clinical Neurosciences, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K. (Perry); Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, U.K. (Perry); QIMR Berghofer Medical Research Institute, Brisbane, Australia (Perry, Breakspear); School of Psychology, College of Science, and Discipline of Psychiatry, College of Health and Medicine, University of Newcastle, Newcastle, Australia (Campbell, Breakspear); Neuroscience Research Australia, Randwick, Australia (Lenroot); University of New Mexico, Albuquerque (Lenroot).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH